Showing results (511-520 of 2,199) with videos related to
Sort By:
Pageof 220
Developments in Biological Standardization|January 1, 1986
In vitro assays for botulinum toxin and antitoxinsC Shone, N Appleton, P Wilton-Smith, et al.Developments in Biological Standardization|January 1, 1978
Report of IABS committee on avian product standardizationD GaudryDevelopments in Biological Standardization|January 1, 1997
Epidemiological determinants of pertussisE Miller, N J GayDevelopments in Biological Standardization|January 1, 1997
The United States research strategy on pertussisJ R La MontagneDevelopments in Biological Standardization|January 1, 1997
Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study GroupM A Uberall, K Stehr, J D Cherry, et al.Developments in Biological Standardization|January 1, 1997
Implications of different study designs for the evaluation of acellular pertussis vaccinesP E FineDevelopments in Biological Standardization|January 1, 1997
Case definitionsS Salmaso, A Moiraghi, A Barale, et al.Developments in Biological Standardization|January 1, 1997
Absolute efficacy of acellular pertussis vaccines in household settingsJ Storsaeter, L GustafssonDevelopments in Biological Standardization|January 1, 1997
Factors influencing the analysis of secondary prevention of pertussisC H Wirsing von König, H J Schmitt, H Bogaerts, et al.Developments in Biological Standardization|January 1, 1997
Diagnostic pertussis serology in the recent clinical efficacy studies of acellular vaccinesH O HallanderPageof 220